List of AI News about Imperial College
| Time | Details |
|---|---|
|
2026-03-12 00:26 |
Google Research and NHS Study Shows AI Boosts Breast Cancer Screening Sensitivity by 25%: Latest Nature Cancer Analysis
According to Jeff Dean, a joint study by Google Research, NHS, and Imperial College published in Nature Cancer shows an AI system detected 25% of interval breast cancers previously missed by conventional screening methods, while maintaining specificity and reducing clinical workloads. As reported by Nature Cancer, the AI significantly increased true positive detection without a meaningful rise in false positives, indicating strong potential for safer triage and quicker turnaround for clinicians and patients. According to Google’s blog, the workflow evaluation suggests AI can prioritize high-risk cases and automate negatives for review, enabling faster reporting and operational efficiency in population screening programs. |
|
2026-03-10 19:18 |
Google’s Mammography AI Shows 25% More Interval Cancer Detection and 40% Workload Reduction: Nature Cancer Analysis
According to Sundar Pichai on X, Google’s experimental mammography AI identified 25% more interval cancers than conventional screening while reducing clinicians’ screening workloads by an estimated 40% in studies with Imperial College London and the NHS. As reported by Nature Cancer and highlighted by Yossi Matias on X, the AI system also detected more invasive cancers and more total cases versus standard methods, indicating meaningful sensitivity gains in real-world screening settings. According to Nature Cancer, these findings suggest operational efficiencies for radiology services and potential earlier detection pathways that could improve patient outcomes and screening throughput in national programs. |
|
2025-06-05 16:17 |
Google DeepMind Launches Academic Fellowship to Advance AI Solutions for Antimicrobial Resistance in 2025
According to @demishassabis, Google DeepMind has officially opened applications for its latest Academic Fellowship, targeting the use of artificial intelligence to address antimicrobial resistance (AMR). This initiative, in collaboration with the Fleming Centre and Imperial College, aims to accelerate research into AI-powered solutions that can predict, prevent, and manage AMR, a growing global health threat. The program presents significant business opportunities for AI startups and healthcare technology companies by fostering innovation in drug discovery, diagnostics, and personalized medicine, as cited from the official Twitter announcement by Demis Hassabis (@demishassabis, June 5, 2025). |
